The global Type 2 Inflammation Targeting Drugs market was valued at 33924 million in 2024 and is projected to reach US$ 105207 million by 2031, at a CAGR of 17.5% during the forecast period.

The global Glucosamine Supplement Capsule market was valued at 1781 million in 2024 and is projected to reach US$ 2773 million by 2031, at a CAGR of 6.6% during the forecast period.

The global Long-Acting HIV-1 Inhibitors market was valued at 317 million in 2024 and is projected to reach US$ 463 million by 2031, at a CAGR of 4.9% during the forecast period.

The global External Semi Solid Preparation market was valued at 3334 million in 2024 and is projected to reach US$ 4784 million by 2031, at a CAGR of 5.6% during the forecast period.

The global Nanoantibody Magnetic Beads market was valued at 288 million in 2024 and is projected to reach US$ 399 million by 2031, at a CAGR of 4.6% during the forecast period.

The global Radix Stemonae Extract market was valued at 43.83 million in 2024 and is projected to reach US$ 76.85 million by 2031, at a CAGR of 8.4% during the forecast period.

The global Eucalyptus Leaf Extract market was valued at 412 million in 2024 and is projected to reach US$ 561 million by 2031, at a CAGR of 4.5% during the forecast period.

The global Pu'er Tea Extract market was valued at 151 million in 2024 and is projected to reach US$ 268 million by 2031, at a CAGR of 8.7% during the forecast period.

The global Alprazolam market was valued at 899 million in 2024 and is projected to reach US$ 1281 million by 2031, at a CAGR of 5.2% during the forecast period.

The global Inhaled Treatment for Asthma and COPD market was valued at 10052 million in 2024 and is projected to reach US$ 13109 million by 2031, at a CAGR of 3.9% during the forecast period.